Legend Capital has closed the LC Healthcare Continued Fund I, having raised USD270 million for a secondary transaction that involves healthcare portfolios of two older vintage funds.
The fund provides liquidity and helped to enhance returns for existing investors while maximising the value of the fund’s portfolio with new follow-on capital.
Legend Capital’s healthcare practice started in 2007, and has since grown into a solid ecosystem across various healthcare segments. The firm has to date deployed USD1.7 billion in healthcare investments, and boasts nearly twenty public companies that are leaders in innovative drugs, biotechnology, medical devices, diagnostic technologies, medical services and digital healthcare sectors. During the past three years, Legend Capital has returned more than USD1.7 billion to its investors from healthcare exits.
Read more at Private Equity Wire
